| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/05/2009 | WO2006134340A9 Oxyntomodulin analogues and their effects on feeding behaviour |
| 03/05/2009 | WO2006069610A8 Process for the production of fine chemicals |
| 03/05/2009 | WO2005094355A3 Methods for altering protein production rates |
| 03/05/2009 | WO2005014618A3 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 03/05/2009 | US20090064378 Novel 7s-alpha regulatory elements for expressing transgenes in plants |
| 03/05/2009 | US20090064375 Paraquat Resistance Gene and a Vascular Tissue- and Trichome-specific Promoter |
| 03/05/2009 | US20090064353 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines |
| 03/05/2009 | US20090062514 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
| 03/05/2009 | US20090062513 Production of bypolymer film, fibre, foam and adhesive materials from soluble s-sulfonated keratin derivative |
| 03/05/2009 | US20090062510 Human Chemotactic Cytokine I Polypeptides |
| 03/05/2009 | US20090062509 Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines |
| 03/05/2009 | US20090062341 Nuclear receptor binding agents |
| 03/05/2009 | US20090062339 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 03/05/2009 | US20090062209 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 03/05/2009 | US20090062207 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 03/05/2009 | US20090062200 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof |
| 03/05/2009 | US20090062199 Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
| 03/05/2009 | US20090062198 Maurotoxin, PI1 and HSTX1 derivatives |
| 03/05/2009 | US20090062197 Sp1 Polypeptides, Modified Sp1 Polypeptides and Uses Thereof |
| 03/05/2009 | US20090062195 Kallikrein-Inhibitor Therapies |
| 03/05/2009 | US20090062194 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/05/2009 | US20090062192 Dimeric Peptide Agonists of the Glp-1 Receptor |
| 03/05/2009 | US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B) |
| 03/05/2009 | US20090062189 Tumor suppressor protein and nucleotide encoding same |
| 03/05/2009 | US20090062188 Disease-Associated Protein |
| 03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
| 03/05/2009 | US20090062184 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 03/05/2009 | US20090062181 Mineral Collagen Chelates And Methods Of Making And Using Same |
| 03/05/2009 | US20090062180 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 03/05/2009 | US20090062142 Methods for enhancing bacterial cell display of proteins and peptides |
| 03/05/2009 | US20090061531 Dna binding protein |
| 03/05/2009 | US20090061521 Recombinant negative strand RNA virus expression systems and vaccines |
| 03/05/2009 | US20090061519 Metabolic regulators |
| 03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
| 03/05/2009 | US20090061459 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 03/05/2009 | US20090061458 Heterooligomeric Taste Receptor |
| 03/05/2009 | US20090061452 Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications |
| 03/05/2009 | US20090061444 Phytochrome-based fluorophores |
| 03/05/2009 | US20090061431 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 03/05/2009 | US20090061427 Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof |
| 03/05/2009 | US20090061421 used to develop novel antibiotics or inhibitors that can prevent an emergence of resistance bacteria; Enterobacter aerogenes |
| 03/05/2009 | US20090061412 Methods for Detecting Papillomavirus DNA in Blood Plasma and Serum |
| 03/05/2009 | US20090060954 Recombinant BCG Vaccine |
| 03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
| 03/05/2009 | US20090060951 Dna vaccine for koi herpes virus (khv) disease |
| 03/05/2009 | US20090060949 Flu vaccines and methods of use thereof |
| 03/05/2009 | US20090060935 Amebiasis vaccine |
| 03/05/2009 | US20090060934 S. agalactiae antigens i & ii |
| 03/05/2009 | US20090060932 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 03/05/2009 | US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060927 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
| 03/05/2009 | US20090060915 Polypeptide, vaccine and use thereof |
| 03/05/2009 | US20090060902 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 03/05/2009 | US20090060901 Detoxification method |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060863 Derivatives of growth hormone and related proteins |
| 03/05/2009 | US20090060862 PEGylation by the Dock and Lock (DNL) Technique |
| 03/05/2009 | CA2698100A1 Compositions and methods of using proislet peptides and analogs thereof |
| 03/05/2009 | CA2698076A1 Metabolic regulators |
| 03/05/2009 | CA2697976A1 A process for producing a peptide hormone |
| 03/05/2009 | CA2697953A1 Lmp of oilseed |
| 03/05/2009 | CA2697935A1 Pathogen control genes and methods of use in plants |
| 03/05/2009 | CA2697729A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | CA2697529A1 Receptor-targeting reagents |
| 03/05/2009 | CA2697480A1 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin |
| 03/05/2009 | CA2697413A1 Modulators of hypersensitivity reactions |
| 03/05/2009 | CA2697370A1 Hiv env proteins with modifications in the v3 loop |
| 03/05/2009 | CA2697361A1 Alpha-synuclein binding diagnostic agent |
| 03/05/2009 | CA2697108A1 Mutant double cyclized receptor peptides inhibiting .beta.1-adrenoceptor antibodies |
| 03/05/2009 | CA2696869A1 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
| 03/05/2009 | CA2696809A1 Method of increasing protein titres |
| 03/05/2009 | CA2695559A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/05/2009 | CA2693707A1 B7-dc variants |
| 03/05/2009 | CA2687681A1 Antigen-binding proteins targeting s. aureus orf0657n |
| 03/05/2009 | CA2684417A1 Plants having increased tolerance to heat stress |
| 03/04/2009 | EP2031390A1 Stabilizing agent and blocking agent |
| 03/04/2009 | EP2031076A1 Novel compositions and methods for cancer |
| 03/04/2009 | EP2031064A1 Method for increasing protein titres |
| 03/04/2009 | EP2031062A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 03/04/2009 | EP2030987A1 S-nitroso group-containing albumin, method for production, and anticancer agent |
| 03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
| 03/04/2009 | EP2030985A1 Transporter genes OATP-B, C, D, and E |
| 03/04/2009 | EP2030983A1 Insecticidal polypeptides and methods of use thereof |
| 03/04/2009 | EP2030015A1 Protein surface remodeling |
| 03/04/2009 | EP2029754A1 Magnetosome gene expression in eukaryotic cells |
| 03/04/2009 | EP2029748A2 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their uses for vaccination and intra-cellular vectorisation |
| 03/04/2009 | EP2029625A2 Use of tgf-beta antagonists in treatment of parathyroid-related disorders |
| 03/04/2009 | EP2029624A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker |
| 03/04/2009 | EP2029623A2 Identification of genes implicated in the virulence of streptococcus agalactiae |
| 03/04/2009 | EP2029622A2 Recombinant vaccine against bluetongue virus |
| 03/04/2009 | EP2029621A2 Blood-brain barrier targeting antibodies |
| 03/04/2009 | EP2029620A1 Ob fold domains |
| 03/04/2009 | EP2029619A2 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp) |
| 03/04/2009 | EP2029175A2 Fermentation and purification of actinomadura chromoprotein and related species |
| 03/04/2009 | EP2029169A2 Recombinant viral vaccine |
| 03/04/2009 | EP2029168A2 Hiv-1 clade a consensus sequences, antigens, and transgenes |